1. Introduction {#sec1-molecules-24-02935}
===============

Antibiotics are widely used in livestock breeding to treat several diseases that appear in all the food producing animal species. To guarantee public health protection, the European Union requires member states to implement yearly monitoring plans to control the presence of antibiotic residues in food. Therefore, surveillance should be aimed particularly at controlling compliance with the maximum residue limits (MRLs), fixed in [Table 1](#molecules-24-02935-t001){ref-type="table"} of the Annex of Regulation (EC) No 37/2010 \[[@B1-molecules-24-02935]\]. For several antibiotics, MRLs have been set in various matrices, such as eggs, fat, honey, kidney, liver, milk, and muscles and still, today, new MRLs are being fixed. In the early 2000s, the liquid chromatography coupled to tandem mass spectrometry technique (LC-QqQ) became essential in the routine analysis of single class of veterinary drug residues in food. Indeed triple quadrupole mass spectrometry analyzers were able to assure both greater sensitivity and selectivity than the traditional LC detectors, based on UV-Vis and fluorescence spectroscopy. In addition, for some important classes, such as aminoglycosides or avermectins, the need of a derivation step could be avoided. In the last ten years, the improvement of LC-QqQ systems allowed the realization of a further step in drug residue analysis, introducing procedures that are able to determine simultaneously more than one drug class \[[@B2-molecules-24-02935],[@B3-molecules-24-02935],[@B4-molecules-24-02935]\]. As consequence, a remarkable effort has been made to progressively replace single-class with multiclass protocols, since this is a cost-effective way to improve the current residue control programs, thereby ensuring the determination of a wide number of compounds, with only few methods. Reviewing the main relevant published papers, some research groups recurred ([Table 1](#molecules-24-02935-t001){ref-type="table"}). Among the control laboratories, the Official Food Control Authority of Zurich (Zurich, Switzerland), the RIKILT (Wageningen, Netherlands), the European Union Reference Laboratory for Antimicrobial Residues in Food (EURL, Fougères, France), the National Institute for Agrarian and Veterinary Research (INIAV, Vila do Conde, Portugal), the Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche (IZSUM, Perugia, Italy), the Canadian Food Inspection Agency (Calgary, Canada), the Residue Analysis Laboratory of Laboratório Nacional Agropecuário (LANAGRO, Porto Alegre, Brazil), and the US Department of Agriculture (USDA, Wyndmoor, PA, USA) are mentioning.

The universities of Barcelona (Spain), Almeria (Spain), and Athens (Greece) have been the most active in this analytical field. LC-QqQ techniques are the most consolidated and most common multiclass procedures for veterinary drugs. These techniques have been mainly developed using this type of equipment \[[@B5-molecules-24-02935],[@B6-molecules-24-02935],[@B10-molecules-24-02935],[@B11-molecules-24-02935],[@B12-molecules-24-02935],[@B16-molecules-24-02935],[@B17-molecules-24-02935],[@B19-molecules-24-02935],[@B20-molecules-24-02935],[@B23-molecules-24-02935],[@B27-molecules-24-02935]\]. In 2008--2009, the Official Food Control Authority of Zurich and the Dutch RIKILT Institute proposed, for the first time, the application of high-resolution (HR) mass spectrometry, based on time-of-flight (TOF) technology \[[@B7-molecules-24-02935],[@B8-molecules-24-02935],[@B9-molecules-24-02935]\]. About three years later, the same Laboratory of Zurich, and the research group of Almeria University developed multiclass procedures for veterinary drugs, respectively, in meat, and milk, using LC-Orbitrap technique, a new MS analyzer, that was commercialized in 2005 \[[@B13-molecules-24-02935],[@B29-molecules-24-02935]\]. Later, the introduction of benchtop hybrid high-resolution mass spectrometers (mainly, Q-TOF and Q-Orbitrap) produced further advantages in terms of selectivity and accuracy and, accordingly, these kinds of equipment has been more commonly applied ([Table 1](#molecules-24-02935-t001){ref-type="table"}) \[[@B14-molecules-24-02935],[@B15-molecules-24-02935],[@B18-molecules-24-02935],[@B21-molecules-24-02935],[@B22-molecules-24-02935],[@B24-molecules-24-02935],[@B25-molecules-24-02935],[@B26-molecules-24-02935],[@B28-molecules-24-02935],[@B29-molecules-24-02935]\].

Based on all the above, multiclass methods are no longer innovative procedures, and there is interest in their wide diffusion. The possibility of easy implementation and sustainable daily management, independent from the available LC-MS equipment. The aim of this work was to discuss the transfer of previously developed multiclass methods for more than sixty antibiotics in meat and milk from an LC-Q-Orbitrap platform to an LC-QqQ one \[[@B24-molecules-24-02935],[@B25-molecules-24-02935]\]. The performance characteristics of the new LC-QqQ methods were estimated by means of full validation studies carried out according to European Commission Decision 2002/657/EC \[[@B30-molecules-24-02935]\]. Finally, a comparison between the two techniques was carried out in the light of their cost-effectiveness in routine analysis of veterinary drug residues.

2. Results and Discussion {#sec2-molecules-24-02935}
=========================

2.1. Optimization of LC-MS/MS Conditions {#sec2dot1-molecules-24-02935}
----------------------------------------

The choice of analytes has been carried out using the most administered antibiotics in farm. Only the classes of aminoglycosides and colistins were excluded, as their high polarity hampers the chromatographic retention, based on the reversed-phase mechanism (C18 column). On the other hand, the addition of ion-pairing agents on the mobile phase produced remarkable ion suppression, with detrimental effects on all the other analytes \[[@B24-molecules-24-02935]\]. The chromatographic conditions were optimized starting from the parameters set for the LC-Q-Orbitrap methods. In order to profitably increase analyte retention, the percentage of methanol (eluent B) was reduced from 5% down to 2% (by volume). According to a typical reversed-phase mechanism, this change allowed us to obtain retention times of about 0.5 min higher than the initial tested conditions ([Figure S1](#app1-molecules-24-02935){ref-type="app"}).

The MS conditions were established without the infusion of the individual solutions of analytes, but by setting the transitions on the basis of the ion fragments previously studied \[[@B24-molecules-24-02935]\]. As shown in [Table 2](#molecules-24-02935-t002){ref-type="table"}, apart few exceptions, such as some beta-lactams (\[M + Na\]^+^), sulfanilamide (\[M + H − NH~3~\]^+^), spiramycin, neospiramycin, cefquinome, tildipirosin, tilmicosin, tulathromycin marker, and tulathromycin (\[M + 2H\]^++^), the selected precursor ion species were generally the protonated molecular ions (\[M + H\]^+^). For macrolides, it is not uncommon for the choice of bi-charged ions to be used as a precursor, due to their favorable abundance among the formed charged species \[[@B31-molecules-24-02935]\]. The sample preparation was exactly the same as that previously optimized by Moretti et al. \[[@B24-molecules-24-02935],[@B25-molecules-24-02935]\]; however, two internal standards (ISs) were replaced, in order to either, decrease costs (metacycline instead of tetracycline-d6), or to improve the MS response (ceftiofur-d3 instead of cefadroxil-d4). In this context, the ISs were not used for quantification purposes, but only to perform the internal quality control by checking the success of the analytical operations, during the routine application of the procedure as well as to monitor the run-to-run differences in the retention times \[[@B8-molecules-24-02935]\]. For this purpose, at the beginning of sample treatment, IS were added at 10 µg·kg^−1^ and, before the release of the results, the presence (S/N \> 3) of all eight compounds must be verified. The analyte quantification was achieved by matrix-matched curves (external standardization), which corrected the concentration for the relevant recovery factor \[[@B32-molecules-24-02935]\]. The LC-QqQ chromatograms of a blank muscle, and of the same spiked at 10 µg·kg^−1^, are reported in [Figure 1](#molecules-24-02935-f001){ref-type="fig"} and [Figure 2](#molecules-24-02935-f002){ref-type="fig"}, respectively. Eight representative analytes are shown, starting from the polar metabolite of florfenicol (florfenicol amine, RT = 3.4 min) to the last eluting compound (rifaximin, RT = 20.7 min). The analogous chromatograms are shown also for milk ([Figure 3](#molecules-24-02935-f003){ref-type="fig"} and [Figure 4](#molecules-24-02935-f004){ref-type="fig"}).

2.2. Method Validation {#sec2dot2-molecules-24-02935}
----------------------

Selectivity requirements are reported in Commission Decision 2002/657/EC \[[@B30-molecules-24-02935]\]. The ion ratio of the two selected transitions ([Table 2](#molecules-24-02935-t002){ref-type="table"}), and their relative retention times (\<2.5%), were checked to confirm analyte identification. Linearity in the matrix was evaluated with five-points matrix-matched curves: 2, 10, 33, 100, and 150 µg·kg^−1^. Therefore, levels higher than 150 µg·kg^−1^ had to be tested, and the final extract was diluted ten-fold or more, as reported in [Tables S1 and S2](#app1-molecules-24-02935){ref-type="app"}. The linearity data are summarized in [Table S3](#app1-molecules-24-02935){ref-type="app"}. For several analytes, the first calibration point (2 µg·kg^−1^) had to be discarded, due to the scarce response. In other more critical cases (e.g., cefacetrile in meat/muscle, tildipirosin and tulathromycin markers in milk) additional points have been removed. Since Commission Decision 657/2002/EC \[[@B30-molecules-24-02935]\] does not furnish precise criteria for evaluating linearity, the "Guidance document on analytical quality control and validation procedures for pesticide residues analysis in food and feed" was followed \[[@B33-molecules-24-02935]\]. The percentage deviation of the back-calculated concentrations (C~measured~) from the true concentrations (C~true~) was calculated (1):$$Deviation~(\%) = \frac{\left( {C_{measured} - C_{true}} \right)}{C_{true}} \cdot 100$$

For each calibration point, it was verified that its value was not more than ± 20%. As an example, the calibration data of six analytes, belonging to different antibiotic families, are reported in [Table S4](#app1-molecules-24-02935){ref-type="app"} and [Figures S2 and S3](#app1-molecules-24-02935){ref-type="app"}.

The overall recoveries and precisions data are listed in [Table 3](#molecules-24-02935-t003){ref-type="table"}. For meat, seven validation levels were performed in the range 10--1500 µg·kg^−1^, whereas, in milk, five levels were investigated (10--333 µg·kg^−1^), with an additional concentration at 2 µg·kg^−1^ to check amoxicillin, ampicillin, and penicillin G accuracy at ½ MRL, as required by the Commission Decision 2002/657/EC \[[@B30-molecules-24-02935]\]. Moreover, in milk, two additional molecules were tested with respect to the original group of 62 compounds, that is, the two quinolones, nalidixic acid, and norfloxacin.

In this work, the classical validation scheme (0.5 MRL, MRL and 1.5 MRL), described in Commission Decision 2002/657/EC, was not applied. Paragraph 3.1.3. of the same decision allows the introduction of alternative models \[[@B30-molecules-24-02935]\] and, since the validation studies of multiclass procedures have to consider dozens of MRLs, which can vary also in function of the animal species, the adoption of progressive validation levels, that are equal for all the analytes, was fully justified. On the other hand, when the Commission Decision was issued (2002), the development of multiclass procedures for the control of veterinary drug residues was not initiated. The spiking ranges were chosen, considering, on the one side, the reachable concentrations, and, on the other side, the relevant MRLs \[[@B1-molecules-24-02935]\] in all the couplings analyte/matrix. Preliminary experiments demonstrated that, at levels lower than 10 µg·kg^−1^, the precision of several amphenicols, macrolides, beta-lactams, and tetracyclines became unsatisfactory.

The recovery factors (Rec) were established by comparing the peak area of each compound in the spiked samples against the peak area in the matrix matched standards, by which the antibiotics were added immediately prior to LC injection. The data in [Table 3](#molecules-24-02935-t003){ref-type="table"} summarize the average recoveries obtained in the whole validation range. In muscles, all recoveries were higher than 70%, except the majority of tetracyclines (62--69%), three beta-lactams (64--68%), and two macrolides (neospiramycin, 67% and tulathromycin, 69%). Analogously, in milk, recoveries higher than 70% were generally obtained, except for the more polar sulfonamides (61--70%) and one macrolide (erythromycin A, 67%). Since the quantification was performed with an external standardization, the raw results were always corrected for the relevant recovery factor, in order to correct the systematic error \[[@B32-molecules-24-02935]\]. With regard to precision, the coefficients of variations (CVs) were calculated at each validation level both, repeatedly, and in intra-lab reproducibility conditions (CV~r~, and CV~wR~, respectively), by applying ANOVA. Moreover the CV~wR~ (and CV~r~) were pooled to obtain an overall precision index, namely CV~wR,pooled~ (2), $$CV_{wR,pooled} = \sqrt{\frac{(n_{1} - 1)CV_{wR1}^{2} + (n_{2} - 1)CV_{wR2}^{2} + ...(n_{n} - 1)CV_{wRn}^{2}}{(n_{1} - 1) + (n_{2} - 1) + ...}}$$ where *CV~wR1~, CV~wR2~ \... CV~wRn~* were the coefficients of variation at the increasing levels 1*, 2 ... n; n~1~, n~2~...n* were the number of replicates at each level \[[@B34-molecules-24-02935]\]. For a certain analyte, the *CV~wR,pooled~* give a single estimate of precision, which can be applied to calculate decision limits (CCα) and detection capabilities (CCβ) at whatever MRL value. Therefore, the *CV~wR,pooled~* can also be used to obtain CCα and CCβ, where new MRLs were fixed in Regulation 37/2010 \[[@B1-molecules-24-02935]\], maximizing the cost-effectiveness of the validation study. The decision limit and detection capability were calculated as follows (equations 3 and 4):$$CC\mathsf{\alpha}_{MRL} = MRL + 1.64 \cdot CV_{wR,pooled} \cdot MRL$$ $$CC\mathsf{\beta}_{MRL} = CC\mathsf{\alpha}_{MRL} + 1.64 \cdot CV_{wR,pooled} \cdot CC\mathsf{\alpha}_{MRL}$$

In [Tables S4 and S5](#app1-molecules-24-02935){ref-type="app"}, the MRLs of the 64 antibiotics, in various food-producing animal species, and in bovine milk, together with the relevant CCαs and CCβs, are listed. The MRLs are those reported in the last consolidated text of Regulation 37/2010 \[[@B1-molecules-24-02935],[@B35-molecules-24-02935]\]. In muscles, valnemulin demonstrated high imprecision (CV~wR,pooled~ = 31%) and, therefore, for these compounds, the developed procedure could be only used for screening purposes ([Table 3](#molecules-24-02935-t003){ref-type="table"}). For all the other antibiotics, CV~wR,pooled~ was always lower than 20%. On the other hand, in milk, cefacetrile and tulathromycin marker demonstrated insufficient precision (CV~wR,pooled~ \> 22%). Matrix effects (ME%) listed in [Table 3](#molecules-24-02935-t003){ref-type="table"} were calculated as follows (equation 5), $$ME(\%) = \frac{b_{MM}}{b_{S}} \times 100$$ where *b*~MM,~ and *b*~S~ were the slopes of matrix matched curves, and solvent standard curves, i.e., curves prepared in ammonium acetate 0.2 M, respectively. In the whole, although the sample purification was scarce, the matrix effects (suppression or enhancement) were limited and very few compounds demonstrated ME (%) higher than \|50\|%. This was probably because the long chromatographic run (30.5 min) allowed the distribution of matrix-interfering compounds and analytes, from preventing excessive bunching \[[@B26-molecules-24-02935]\].

Since the signal-to-noise approach (S/N) is rather subjective \[[@B36-molecules-24-02935]\], "operative" (fit for purpose) LOD and LOQ were fixed by examining the precision at each validation level ([Table S7](#app1-molecules-24-02935){ref-type="app"}). All the compounds were detectable at the first concentration, i.e., 2 µg·kg^−1^ for amoxicillin, ampicillin, and penicillin G in milk and 10 µg·kg^−1^ for all the others. The only exception was cefacetrile, which is a scarcely ionizable molecule and, therefore, detectable and quantifiable from 33 µg·kg^−1^ in muscle (CV~r~ = 13%, CV~wR~ = 14%, recovery = 76%) and only detectable in milk (insufficient precision). A satisfactory accuracy for both amoxicillin and ampicillin was obtained at 2 µg·kg^−1^, whereas penicillin G demonstrated unsatisfactory precision at this level (CV~r~ = 23%, CV~wR~ = 26%) and, therefore, this beta-lactam could be quantified only starting from 10 µg·kg^−1^ (CV~r~ = 7.5%, CV~wR~ = 11%). Therefore, penicillin G, a fundamental drug for the treatment of sub-clinical mastitis in **lactating cows**, could not be quantified in milk at ½ MRL (2 µg·kg^−1^) and the method was suitable only for screening purpose \[[@B30-molecules-24-02935]\]. In [Figure S4](#app1-molecules-24-02935){ref-type="app"} the LC-QqQ chromatograms of these three compounds are shown in a blank milk sample and in the same sample spiked at 2 µg·kg^−1^.

2.3. Comparison of LC-QqQ and LC-Q-Orbitrap Methods {#sec2dot3-molecules-24-02935}
---------------------------------------------------

Comparing the recovery factors of the methods developed in meat, similar results were always obtained (differences \< 15%), except for cefquinome, which demonstrated a higher recovery when LC-QqQ was applied (+ 26%: 97% LR vs. 71% HR) and valnemulin which, nevertheless, was not accurately quantifiable with the LR procedure, as discussed above. The recovery differences are visualized in [Figure S5](#app1-molecules-24-02935){ref-type="app"}. Examining the data of the more polar cephalosporins (desacetylcephapirin, cephapirin, cefacetrile and cefalonium), cefquinome recovery appeared suspect (over-estimated) using QqQ technique. Since the sample preparation protocol was the same, this difference should be attributed to an instrumental technique. Interestingly, cefquinome co-eluted with sulfamerazine and, in addition, accidentally their precursor ion had the same nominal mass charge ratio i.e., *m*/*z* 265 ([Table 2](#molecules-24-02935-t002){ref-type="table"}). In our laboratory, at the beginning of the development of multiclass methods for antibiotics in food (2014), two separate matrix-matched curves were prepared, one for beta-lactams and another for all other analytes \[[@B24-molecules-24-02935]\]. This measure was precautionary in order to avoid the possible negative effects of methanol, contained in the intermediate solution of antibiotics other than beta-lactams (see [Section 2.2](#sec2dot2-molecules-24-02935){ref-type="sec"}) on beta-lactam stability, as described in the literature \[[@B37-molecules-24-02935],[@B38-molecules-24-02935]\]. In saying that, the artefacts in the quantification of cefquinome and/or sulfamerazine could occur if "hidden" transitions were shared between these two compounds. This means that a transition, monitored only for one of the two analytes ([Table 2](#molecules-24-02935-t002){ref-type="table"}), was shared by the other one, too. In order to verify this hypothesis, two individual solutions (50 ng·mL^−1^) were separately injected, by simultaneously monitoring the four relevant SRMs ([Figure S6](#app1-molecules-24-02935){ref-type="app"}). It was evident that sulfamerazine shared a "hidden" transition with cefquinome (*m*/*z* 265 \> *m*/*z* 199---left side of [Figure S6](#app1-molecules-24-02935){ref-type="app"}), but also viceversa (*m*/*z* 265 \> *m*/*z* 156---right side of [Figure S6](#app1-molecules-24-02935){ref-type="app"}). For sulfamerazine the fragment ion species at *m*/*z* 199 was formed by the rearrangement ion, by losing H~2~SO~2~ from the protonated molecule \[[@B39-molecules-24-02935]\]. On the other hand, for cefquinome, the ion *m*/*z* 156 derived by the cleavage of C-C bond between oxime and the carbonyl group of C^7^ amide (\[C~5~H~6~N~3~OS\]^+^) of the beta-lactam ring \[[@B40-molecules-24-02935]\]. However, from a quantitative point of view, sulfamerazine could notably affect the peak area of cefquinome, but the contrary was much less, since sulfamerazine responded more significantly than cefquinome (about 4.9 × 10^6^ vs. 1.1 × 10^6^). Accordingly, when sulfamerazine was co-present, cefquinome concentration was significantly over-estimated. Later, observing that, in the adopted experimental conditions, beta-lactams were not deteriorated by methanol, the validation study in milk was performed by preparing only one matrix-matched calibration curve with all the analytes, including beta-lactams. In summary, although the development of LR procedures has been very fast and effective, due to previously-studied conditions \[[@B24-molecules-24-02935],[@B25-molecules-24-02935]\], for one analyte, i.e., cefquinome, the choice of the precursor ion should be re-evaluated.

In [Figure S7](#app1-molecules-24-02935){ref-type="app"} the differences between LR and HR recovery factors in milk are shown. Tulathromycin marker and cefquinome had better recovery rates using HR detection, whereas valnemulin, cloxacillin, and rifaximin, showed better results using the LR system. As reported in our previous paper \[[@B25-molecules-24-02935]\], LC-Q-Orbitrap suffers from "post interface ion suppression", which consists of instrument saturation when intense matrix-related compounds are present \[[@B41-molecules-24-02935]\]. This phenomenon was more pronounced for the last eluting compounds, such as valnemulin, cloxacillin, and rifaximin, which explains the observed data in milk extracts. These have more interfering substances with respect to muscle \[[@B25-molecules-24-02935]\]. Comparing the precision data (intra-laboratory reproducibility, CV~wR,pooled~, see [Tables S8 and S9](#app1-molecules-24-02935){ref-type="app"}), remarkable differences (≥15%) between the two techniques were observed only in milk and, again, tulathromycin marker and cefquinome revealed the worse performances when determined by LC-QqQ. C~wR,pooled~ of tylosin, cloxacillin, and tylvalosin were about 10% higher when analyzed by LC-Q-Orbitrap ([Figure S9](#app1-molecules-24-02935){ref-type="app"}).

According to accreditation rules \[[@B42-molecules-24-02935]\], since 2014 our laboratory participated in Proficiency Test Schemes in meat and milk, by applying the LC-Q-Orbitrap methods in these products. Some of the stored test materials were then re-tested, by applying the new developed procedures. The results, together with the consensus values assigned by the Organizers, are listed in [Table 4](#molecules-24-02935-t004){ref-type="table"}. Examining the acceptability ranges, satisfactory z-scores would have been always obtained, except in the case of amoxicillin in milk (sample code: MI1532-A1). This latter result was explainable with the well-known instability of penicillin antibiotics \[[@B43-molecules-24-02935],[@B44-molecules-24-02935]\].

In summary, the main advantages and disadvantages of the two techniques are undoubtedly, the QqQ analyser, which only involves only a kind of acquisition, i.e., SRM mode. On the contrary, Q-Orbitrap forces more complex experiments, also because the detection of analytes at trace levels is complicated by the "post interface ion suppression" phenomenon. On this subject, we demonstrated that, in certain chromatographic regions, for milk it is not possible to reach the required limits using full-scan experiments, since the massive presence of interfering substances can drastically worsen the sensitivity \[[@B25-molecules-24-02935]\]. With regard to the sample throughput, the sample preparation protocol is identical and, therefore, there is no great difference. Moreover, it must be highlighted that some performances of LR system are due to the obsolescence of the available equipment. For example, most likely, a more recent LR platform could reach comparable LODs with HR, i.e., lower than 10 µg·kg^−1^. All that said, the LC-QqQ technique is more suitable for routine laboratories, considering its user-friendliness and lesser cost (about three time lesser than LC-Q-Orbitrap).

3. Experimental {#sec3-molecules-24-02935}
===============

3.1. Chemical and Reagents {#sec3dot1-molecules-24-02935}
--------------------------

Acetonitrile (ACN) and methanol (LC-MS grade) were from Carlo Erba Reagents (Milan, Italy). Formic acid (50%) and *N*,*N'*-dimethylformamide (DMF) were purchased from Sigma-Aldrich (St. Louis, MO, USA). EDTA sodium salt dehydrate and ammonium acetate were provided by Sigma-Aldrich. Ultra-pure deionized water was generated by a Milli-Q purification apparatus (Millipore, Bedford, MA, USA). Amoxicillin, ampicillin, cloxacillin, dicloxacillin, nafcillin, oxacillin, penicillin G (benzylpenicillin), penicillin G-d7, penicillin V (phenoxymethylpenicillin), cefalonium, cefoperazone, cefquinome, ceftiofur, cephalexin, ciprofloxacin, danofloxacin, difloxacin, enrofloxacin, flumequine, marbofloxacin, nalidixic acid, norfloxacin, oxolinic acid, sarafloxacin, erithromycin A, spiramycin I, tylosin A, tilmicosin, sulfadiazine, sulfaguanidine, sulfadimethoxine, sulfamerazine, sulfamethazine (sulfadimidine), sulfamethoxazole, sulfanilamide, sulfapyridine, sulfaquinoxaline, sulfathiazole, trimethoprim, chlortetracycline, doxycycline, metacycline, oxytetracycline, tetracycline, florfenicol, florfenicol amine, thiamphenicol, lincomycin, rifaximin, tiamulin and valnemulin were obtained from Sigma-Aldrich. Sulfamonomethoxine was purchased from Dr. Ehrenstorfer (Augsburg, Germany); cefazolin, cefacetrile, ceftiofur-d3, cephapirin, desacetylcephapirin, florfenicol-d3, 3-*O*-acetyltylosin, gamithromycin, neospiramycin, spiramycin I-d3, tildipirosin, tulathromycin, tylvalosin, 4-epi-chlortetracycline, 4-epi-tetracycline, 4-epi-oxytetracycline, and tulathromycin marker (CP-60,300) were purchased from TRC Inc. (Toronto, Canada); sulfamethazine-^13^C6, sulfanilamide-^13^C6 and enrofloxacin-d5 were obtained from WITEGA (Berlin, Germany).

3.2. Standard Solutions {#sec3dot2-molecules-24-02935}
-----------------------

Individual stock standard solutions of 100 µg·mL^−1^ were prepared with methanol (amphenicols, lincosamides, macrolides, pleuromutilins, sulphonamides, tetracyclines and trimethoprim). The solubilization and storage conditions were previously studied \[[@B24-molecules-24-02935]\]. Beta lactams were solubilized in H~2~O/ACN 75/25 (*v*/*v*), except ceftiofur (DMF). Quinolones in MeOH/H~2~O 80/20 (*v*/*v*), except ciprofloxacin, nalidixic acid, norfloxacin, enrofloxacin and oxolinic acid (DMF). Rifaximin was prepared in MeOH/H~2~O 50/50 (*v*/*v*). The stock solutions were stored at −20 °C with variable storage times: From 1 month (cefquinome) to 24 months (sulphonamides). Working solutions (10, 1 and 0.1 µg·mL^−1^) were prepared from the relevant stock solutions diluting with H~2~O/ACN 75/25 (*v*/*v*) for beta-lactams and with methanol for all the other antibiotics. The solutions of internal standards were prepared according to their native compound or class.

3.3. LC-MS-MS Conditions {#sec3dot3-molecules-24-02935}
------------------------

LC-MS/MS measurements were performed by a Surveyor LC pump, coupled with a triple quadrupole mass spectrometer (TSQ Quantum Ultra, Thermo Fisher, San Jose, CA, USA), an electrospray source included, and operating in a positive ionization mode. Separation was achieved on a Poroshell 120 EC-C18 column (3.0 × 100 mm; 2.7 μm particle diameter), which was connected to a guard column Poroshell (2.1 × 5 mm), both from Agilent Technologies (Santa Clara, CA, USA). The flow rate used was 0.25 mL·min^−1^ and the column temperature set at 30 °C. Mobile phase A was an aqueous solution 0.1% (*v*/*v*) formic acid and eluent B methanol. The gradient profile started at 2% eluent B for 1 min and increased linearly up to 95% B in 19.5 min; this condition was maintained for 5 min before returning to initial condition in 1 min (2% B) and held for 4 min to equilibrate the column. The sample temperature was kept at 16 °C and the injection volume 10 µL. For MS detection, the parameters were the follows: Capillary temperature 300 °C, vaporizer 320 °C, spray voltage 3 kV, and a resolution setting of Q1 and Q3 *m*/*z* 0.7. Sheath gas and auxiliary gas (nitrogen) pressures were set at 35, and 15 arbitrary units, respectively. Collision gas (argon) pressure: 1.5 mtorr. The collision energies, that were associated with each transition, are listed in [Table 2](#molecules-24-02935-t002){ref-type="table"}.

3.4. Sample Preparation {#sec3dot4-molecules-24-02935}
-----------------------

The sample preparation was described elsewhere \[[@B24-molecules-24-02935],[@B25-molecules-24-02935]\]. Briefly, (1.50 ± 0.01) g of minced muscle or milk were weighed in a 50 mL Falcon tube. The sample was spiked with: (i) 15 µL of the solution of the two internal standards (ISs) of beta-lactams at 1 µg·mL^−1^ (ceftiofur-d3 and penicillin G-d7); (ii) 15 µL of the solution of the other six ISs (sulfanilamide-^13^C6, sulfamethazine-^13^C6, enrofloxacin-d5, florfenicol-d3, spiramycin-d3 and metacycline) at 1 µg mL^−1^. For muscles, one hundred microliters of 0.1 M of EDTA was then added, and the sample was extracted with 3 mL of a mixture of acetonitrile/water 80/20 (*v*/*v*). Milk was extracted with one milliliter of 0.1 M of EDTA and 3 mL of acetonitrile. A second extraction with 3 mL of pure acetonitrile was performed for both matrices. After centrifugation, the reunited extracts were evaporated and solubilized in 1.5 mL of ammonium acetate 0.2 M. Ten µL was injected in the LC system.

3.5. Method Validation {#sec3dot5-molecules-24-02935}
----------------------

The validation was carried out following the Commission Decision 2002/657/EC \[[@B30-molecules-24-02935]\]. To test the selectivity, blank muscle samples, belonging to the main animal species (bovine, swine and poultry) and bovine milk samples from different origins, were analyzed. The linearity in the matrix has been evaluated in the range 2--150 µg·kg^−1^ (2, 10, 33, 100 and 150 µg·kg^−1^). The matrix-matched solutions were prepared by adding the analytes immediately prior to LC injection. The curves were constructed, including at zero (blank), and by plotting the average peak area of analyte (three injections for each concentration point) against its concentration. An unweighted linear regression model was applied to the calibration data. The precision (repeatability and within-laboratory reproducibility), recovery (trueness), decision limit (CCα), and detection capability (CCβ) were studied following the experimental plans, described in [Table S1](#app1-molecules-24-02935){ref-type="app"} (muscle) and [Table S2](#app1-molecules-24-02935){ref-type="app"} (milk) of the [Supplementary Material](#app1-molecules-24-02935){ref-type="app"}. A blank bovine muscle or milk was spiked at the beginning of the extraction procedure with the appropriate standard solutions. Four replicates (*n* = 4) at each level were carried out on the same day, along with the relevant matrix-matched calibration curve. Each series was repeated on three different days, and at varying times, operator, and calibration status of the LC-MS system. The spiking levels in muscles were; 10, 33, 100, 150, 333, 1000, and 1500 µg·kg^−1^ and 10, 33, 100, 150, and 333 µg kg^−1^ in milk. In milk, penicillin G, amoxicillin, and ampicillin were also tested at 2 µg·kg^−1^. The Limits of Detection (LODs ) and Quantification (LOQs) were estimated on the basis of the observed accuracy (recovery and precision) at the first validation concentration or, if necessary, at the second one.

4. Conclusions {#sec4-molecules-24-02935}
==============

The validity of the transfer, from LC-Q-Orbitrap to LC-QqQ of two multiclass methods for veterinary drugs in food, has been demonstrated. Using the LR platform, valnemulin in muscle, cefacetrile, and tulathromycin marker in milk did not reach acceptable precision. In addition, examining LC-QqQ results, a series of accidental events (co-elution, selected precursor ions, fragmentation pathway etc) produced an over-estimation of cefquinome in meat, due to the co-presence of sulfamerazine. If neglected, this phenomenon could give false positive results. Since the quantification process of the LC-Q-Orbitrap system was based on a different principle (peak area of the precursor ion measured with MS accuracy \< 5 ppm), this drawback was not observed. However, in milk, LC-Q-Orbitrap achieved worse recoveries for some of the more non-polar analytes, eluting in the chromatographic zone in which the interfering substances were more abundant. The "post interface ion suppression", which is a specific phenomenon of Orbitrap mass analysers could explain this latter evidence. A further consideration concerns the chromatographic separation, which is fundamental when highly selective detectors are applied. A good separation of peaks, avoiding the overlapping and bunching of both analytes and endogenous substances, minimizes the risk of false positive results and reduces matrix effects. Finally, the described method transfer has been successfully performed on an obsolete LC-QqQ platform (fifteen year-old), encouraging the implementation of multiclass strategy also in routine laboratories with limited instrumental resources.

**Sample Availability:** Not available.

The following are available online, Figure S1: LC-QqQ chromatograms of the three more polar analytes (sulfanilamide, sulfaguanidine and florfenicolamine) with different % MeOH at the beginning of the gradient: 2% (left) and 5% (right), Figure S2: Matrix-matched calibration curves of danofloxacin, doxycycline, oxacillin, spiramycin, sulfamethazine and tiamulin in meat, Figure S3: Matrix-matched calibration curves of of danofloxacin, doxycycline, oxacillin, spiramycin, sulfamethazine and tiamulin in milk, Figure S4: LC-QqQ chromatograms of a blank (a) and a milk sample spiked at 2 μg kg^-1^ (b) of the three penicillins with MRL at 4 μg kg^-1^, Figure S5: Recovery differences between the LC-QqQ and LC-Q-Orbitrap methods in meat. Positive values (%) indicate better recovery of LC-QqQ procedure and vice versa, Figure S6: LC-QqQ chromatograms of individual solutions (50 ng mL^-1^) of sulfamerazine (left) and cefquinome (right), Figure S7: Recovery differences between the LC-QqQ and LC-Q-Orbitrap methods in bovine milk. Positive values (%) indicate better recovery of LC-QqQ procedure and vice versa, Figure S8: Precision differences between the LC-QqQ and LC-Q-Orbitrap methods in meat. Positive values (%) indicate better precision of LC-QqQ procedure and vice versa, Figure S9: Precision differences between the LC-QqQ and LC-Q-Orbitrap methods in bovine milk. Positive values (%) indicate better precision of LC-QqQ procedure and vice versa, Table S1: Validation plan in bovine muscle, Table S2: Validation plan in milk, Table S3: Linearity studies in matrix (matrix-matched curves), Table S4: Calibration data (matrix-matched curves) of six representative analytes, Table S5: MRL (μg kg^-1^), decision limits (μg kg^-1^) and detection capabilities (μg kg^-1^) of the 64 tested antibiotics in the main food-producing species, Table S6: MRL (μg kg^-1^), decision limits (μg kg^-1^) and detection capabilities (μg kg^-1^) of the 64 antibiotics in aquaculture, rabbits, horses, Table S7: Estimated LODs and LOQs based on the observed accuracy at the first and at the second validation level.

###### 

Click here for additional data file.
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molecules-24-02935-t001_Table 1

###### 

Overview of multiclass methods for the determination of veterinary drug residues in tissues and milk.

       N° of Veterinary Drugs   Matrix                Equipment                       Reference                                                  Laboratory/Centre ^a^
  ---- ------------------------ --------------------- ------------------------------- ---------------------------------------------------------- -------------------------------
  1    18                       Milk                  LC-QqQ                          Aguilera-Luiz et al. 2008 \[[@B5-molecules-24-02935]\]     Almeria University (Spain)
  2    39                       Chicken muscle        LC-QqQ                          Chico et al. 2008 \[[@B6-molecules-24-02935]\]             Barcelona University (Spain)
  3    \>100                    Muscle                LC-TOF                          Kaufmann et al. 2008 \[[@B7-molecules-24-02935]\]          OFCA-Zurich (Switerland)
  4    \>100                    Milk                  LC-TOF                          Stolker et al. 2008 \[[@B8-molecules-24-02935]\]           RIKILT (The Netherlands)
  5    Ca 100                   Meat and other food   LC-TOF                          Peters et al. 2009 \[[@B9-molecules-24-02935]\]            RIKILT (The Netherlands)
  6    Ca 26                    Animal tissues        LC-QqQ                          Stubbings et al. 2009 \[[@B10-molecules-24-02935]\]        FERA (UK)
  7    58                       Milk                  LC-QqQ                          Gaugain-Juhel et al. 2009 \[[@B11-molecules-24-02935]\]    EURL (France)
  8    21                       Milk                  LC-QqQ                          Martinez-Vidal et al. 2010 \[[@B12-molecules-24-02935]\]   Almeria University (Spain)
  9    30                       Milk                  LC-Orbitrap, LC-Q-TOF, LC-QqQ   Romero-González et al. 2011 \[[@B5-molecules-24-02935]\]   Almeria University (Spain)
  10   \>100                    Meat and other food   LC-Orbitrap                     Kaufmann et al. 2011 \[[@B13-molecules-24-02935]\]         OFCA-Zurich (Switzerland)
  11   \>60                     Meat                  LC-LTQ-Orbitrap                 Hurtaud-Pessel et al. 2011 \[[@B14-molecules-24-02935]\]   EURL (France)
  12   59                       Milk and honey        LC-Q-TOF                        Wang et al. 2012 \[[@B15-molecules-24-02935]\]             CFIA-Calgary (Canada)
  13   21                       Meat                  LC-QqQ                          Bittencourt et al. 2012 \[[@B16-molecules-24-02935]\]      LANAGRO (Brazil)
  14   24                       Milk and liver        LC-QqQ                          Martins et al. 2014 \[[@B17-molecules-24-02935]\]          LANAGRO (Brazil)
  15   \>100                    Milk                  LC-Q-Orbitrap                   Kaufmann et al. 2014 \[[@B18-molecules-24-02935]\]         OFCA-Zurich (Switzerland)
  16   39                       Liver                 LC-QqQ                          Freitas et al. 2015 \[[@B19-molecules-24-02935]\]          INIAV (Portugal)
  17   23                       Liver                 LC-QqQ                          Martins et al. 2015 \[[@B20-molecules-24-02935]\]          LANAGRO (Brazil)
  18   \>100                    Milk                  LC-Q-Orbitrap                   Wang et al. 2015 \[[@B21-molecules-24-02935]\]             CFIA-Calgary (Canada)
  19   \>100                    Various food          LC-Q-TOF                        Dasenaki et al. 2015 \[[@B22-molecules-24-02935]\]         University of Athens (Greece)
  20   76                       Bovine muscle         LC-QqQ                          Dasenaki et al. 2016 \[[@B23-molecules-24-02935]\]         University of Athens (Greece)
  21   62                       Animal muscle         LC-Q-Orbitrap                   Moretti et al. 2016 \[[@B24-molecules-24-02935]\]          IZSUM (Italy)
  22   62                       Milk                  LC-Q-Orbitrap                   Moretti et al. 2016 \[[@B25-molecules-24-02935]\]          IZSUM (Italy)
  23   \>120                    Animal tissues        LC-QqQ/LC-Q-TOF                 Anumol et al. 2017 \[[@B26-molecules-24-02935]\]           USDA (USA)
  24   174                      Bovine tissues        LC-QqQ                          Lehotay et al. 2018 \[[@B27-molecules-24-02935]\]          USDA (USA)
  25   44                       Salmon                LC-Q-TOF                        Gaspar et al. 2019 \[[@B28-molecules-24-02935]\]           INIAV (Portugal)

^a^ OFCA = Official Food Control Authority; CFIA:Canada Food Inspection Agency; FERA: The Food and Environment Research Agency; LANAGRO: Laboratório Nacional Agropecuário; INIAV: Instituto Nacional de Investigação Agrária e Veterinária; USDA: United States Department of Agriculture; IZSUM: Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche.

molecules-24-02935-t002_Table 2

###### 

Summary of the selected reactions transitions (SRM) monitored for the sixty-four targeted analytes.

  N°      Analyte                 Retention Time (min)   Adduct (*m*/*z*)       Precursor Ion (*m*/*z*)   Product Ions (*m*/*z*)   Collision Energy (eV)
  ------- ----------------------- ---------------------- ---------------------- ------------------------- ------------------------ -----------------------
  1       Sulfaguanidine          2.85                   \[M + H\]^+^           215.1                     92.0                     15
  156.0   20                                                                                                                       
  2       Florfenicolamine        3.20                   \[M + H\]^+^           248.1                     230.1                    10
  130.1   30                                                                                                                       
  3       Sulfanilamide           3.30                   \[M + H − NH~3~\]^+^   156.0                     92.0                     12
  108.1   10                                                                                                                       
          Sulfanilamide-13C6      3.30                   \[M + H − NH~3~\]^+^   162.0                     98.1                     13
  114.1   13                                                                                                                       
  4       Desacetylcephapyrin     6.80                   \[M + H\]^+^           382.1                     152.0                    30
  226.0   20                                                                                                                       
  5       Amoxicillin             8.30                   \[M + H\]^+^           366.1                     349.1                    10
  114.0   20                                                                                                                       
  6       Sulfadiazine            8.50                   \[M + H\]^+^           251.1                     108.0                    26
  156.0   15                                                                                                                       
  7       Sulfathiazole           9.20                   \[M + H\]^+^           256.0                     92.1                     28
  156.0   15                                                                                                                       
  8       Cephapyrin              9.45                   \[M + H\]^+^           424.1                     292.1                    20
  152.0   30                                                                                                                       
  9       Sulfapyridine           9.50                   \[M + H\]^+^           250.1                     108.0                    26
  156.0   17                                                                                                                       
  10      Tildipirosin            9.90                   \[M+2H\]^++^           367.7                     281.2                    20
  98.1    18                                                                                                                       
  11      Sulfamerazine           9.90                   \[M + H\]^+^           265.1                     108.0                    27
  156.0   17                                                                                                                       
  12      Cefquinome              10.00                  \[M + 2H\]^++^         265.1                     134.2                    20
  199.1   20                                                                                                                       
  13      Cefacetrile             10.15                  \[M + Na\]^+^          362.0                     258.0                    10
  302.0   10                                                                                                                       
  14      Cefalonium              10.50                  \[M + H\]^+^           459.1                     337.0                    10
  152.0   20                                                                                                                       
  15      Lincomycin              10.50                  \[M + H\]^+^           407.2                     126.1                    30
  359.2   10                                                                                                                       
  16      Tulathromycin marker    10.60                  \[M + 2H\]^++^         289.0                     158.3                    17
  420.5   17                                                                                                                       
  17      Thiamphenicol           10.60                  \[M + H\]^+^           356.0                     308.0                    20
  229.0   20                                                                                                                       
  18      Epitetracycline         10.60                  \[M + H\]^+^           445.2                     410.2                    20
  392.1   30                                                                                                                       
  19      Trimethoprim            10.70                  \[M + H\]^+^           291.1                     261.1                    30
  230.1   30                                                                                                                       
  20      Marbofloxacin           10.80                  \[M + H\]^+^           363.1                     276.1                    14
  320.1   14                                                                                                                       
  21      Sulfamethazine          11.10                  \[M + H\]^+^           279.1                     92.1                     31
  124.1   28                                                                                                                       
          Sulfamethazine-^13^C6   11.10                  \[M + H\]^+^           285.1                     186.1                    17
  22      Epioxytetracycline      11.35                  \[M + H\]^+^           461.2                     426.1                    20
  337.1   30                                                                                                                       
  23      Norfloxacin^a^          11.50                  \[M + H\]^+^           320.1                     231.2                    39
  282.1   29                                                                                                                       
  24      Tetracycline            11.50                  \[M + H\]^+^           445.2                     410.2                    20
  392.1   30                                                                                                                       
  25      Cefalexin               11.70                  \[M + H\]^+^           348.1                     158.0                    10
  174.1   20                                                                                                                       
  26      Oxytetracycline         11.80                  \[M + H\]^+^           461.2                     426.1                    20
  337.1   30                                                                                                                       
  27      Ciprofloxacin           11.80                  \[M + H\]^+^           332.1                     245.1                    23
  288.1   17                                                                                                                       
  28      Enrofloxacin            11.90                  \[M + H\]^+^           360.2                     245.0                    26
  316.1   19                                                                                                                       
          Enrofloxacin -d5        11.90                  \[M + H\]^+^           365.2                     321.4                    18
  29      Tulathromycin           11.90                  \[M + 2H\]^++^         404.0                     158.1                    20
  116.1   20                                                                                                                       
  30      Danofloxacin            11.95                  \[M + H\]^+^           358.2                     283.1                    24
  340.1   22                                                                                                                       
  31      Cefazolin               12.00                  \[M + H\]^+^           455.0                     323.1                    10
  156.0   20                                                                                                                       
  32      Sulfamethoxazole        12.10                  \[M + H\]^+^           254.1                     108.1                    28
  156.0   16                                                                                                                       
  33      Difloxacin              12.30                  \[M + H\]^+^           400.1                     299.1                    28
  356.1   18                                                                                                                       
  34      Ampicillin              12.30                  \[M + H\]^+^           350.1                     106.1                    20
  160.0   20                                                                                                                       
  35      Sulfamonomethoxine      12.30                  \[M + H\]^+^           281.1                     108.1                    28
  156.0   16                                                                                                                       
  36      Florfenicol             12.40                  \[M + H\]^+^           358.0                     241.0                    20
  340.0   10                                                                                                                       
          Florfenicol -d3         12.40                  \[M + H\]^+^           361.0                     241.0                    16
  37      Cefoperazone            12.60                  \[M + H\]^+^           646.1                     530.3                    10
  143.1   30                                                                                                                       
  38      Sarafloxacin            12.60                  \[M + H\]^+^           386.1                     342.1                    18
  299.1   26                                                                                                                       
  39      Epichlortetracycline    12.85                  \[M + H\]^+^           479.1                     444.1                    20
  154.0   30                                                                                                                       
  40      Neospiramycin           13.40                  \[M + 2H\]^++^         350.2                     160.1                    10
  174.1   20                                                                                                                       
  41      Chlortetracycline       13.80                  \[M + H\]^+^           479.1                     441.1                    20
  154.0   30                                                                                                                       
  42      Spiramycin              14.05                  \[M + 2H\]^++^         422.3                     702.4                    10
  174.1   20                                                                                                                       
          Spiramycin -d3          14.05                  \[M + 2H\]^++^         423.8                     174.0                    20
  43      Sulfadimethoxine        14.40                  \[M + H\]^+^           311.1                     108.1                    29
  156.0   21                                                                                                                       
  44      Sulfaquinoxaline        14.80                  \[M + H\]^+^           301.1                     92.1                     30
  156.0   21                                                                                                                       
  45      Oxolinic Acid           15.00                  \[M + H\]^+^           262.1                     216.0                    29
  244.0   18                                                                                                                       
  46      Ceftiofur               15.10                  \[M + H\]^+^           524.0                     241.0                    20
  126.0   30                                                                                                                       
          Ceftiofur-d3            15.10                  \[M + H\]^+^           527.0                     244.1                    15
          Metacycline             15.15                  \[M + H\]^+^           443.1                     426.2                    16
  47      Gamithromycin           15.40                  \[M + H\]^+^           777.5                     158.1                    39
  619.7   32                                                                                                                       
  48      Tilmicosin              15.70                  \[M + 2H\]^++^         435.3                     695.5                    20
  174.1   30                                                                                                                       
  49      Doxycycline             15.50                  \[M + H\]^+^           445.2                     428.1                    10
  321.1   35                                                                                                                       
  50      Nalidixic Acid^a^       16.80                  \[M + H\]^+^           233.1                     159.0                    30
  187.0   25                                                                                                                       
  51      Tiamulin                17.10                  \[M + H\]^+^           494.3                     192.1                    20
  119.0   30                                                                                                                       
  52      Penicillin G            17.15                  \[M + Na\]^+^          357.1                     198.1                    20
  182.0   20                                                                                                                       
          Penicillin G-d7         17.15                  \[M + Na\]^+^          364.0                     205.2                    13
  53      Flumequine              17.20                  \[M + H\]^+^           262.1                     202.0                    33
  244.0   19                                                                                                                       
  54      Tylosina A              17.40                  \[M + H\]^+^           916.5                     174.1                    36
  772.5   28                                                                                                                       
  55      Erythromycin            17.60                  \[M + H\]^+^           734.5                     576.4                    20
  158.1   30                                                                                                                       
  56      3-O-Acetyltylosin       17.75                  \[M + H\]^+^           958.5                     174.0                    36
  772.5   28                                                                                                                       
  57      Oxacillin               18.20                  \[M + Na\]^+^          424.1                     265.1                    20
  182.0   20                                                                                                                       
  58      Penicillin V            18.20                  \[M + Na\]^+^          373.1                     182.0                    20
  214.0   20                                                                                                                       
  59      Cloxacillin             18.50                  \[M + Na\]^+^          458.1                     299.0                    20
  182.0   20                                                                                                                       
  60      Valnemulin              19.10                  \[M + H\]^+^           565.4                     263.1                    20
  72.1    30                                                                                                                       
  61      Dicloxacillin           19.20                  \[M + Na\]^+^          492.0                     333.0                    20
  182.0   20                                                                                                                       
  62      Nafcillin               19.30                  \[M + H\]^+^           415.1                     171.1                    34
  199.1   13                                                                                                                       
  63      Tilvalosin              19.45                  \[M + H\]^+^           1042.6                    174.0                    39
  814.5   30                                                                                                                       
  64      Rifaximin               20.60                  \[M + H\]^+^           786.4                     754.3                    20
  736.3   30                                                                                                                       

^a^ Acquired only in milk.

molecules-24-02935-t003_Table 3

###### 

Precision, recovery and matrix effect (muscle and milk).

                          Muscle   Milk                                    
  ----------------------- -------- ------ ---- --------- ----- ----- ----- ---------
  Sulfaguanidine          5.8      10     83   −14       5.0   14    61    **253**
  Florfenicol Amine       3.2      6.1    85   **−22**   2.5   3.8   94    −13
  Sulfanilamide           6.6      8.9    74   **−35**   5.8   12    66    **−21**
  Desacetylcephapirin     7.6      7.3    76   −1        5.9   6.0   91    **−21**
  Amoxicillin             4.5      6.3    64   −1        5.8   5.8   89    −10
  Sulfadiazine            5.1      8.2    86   −18       4.8   8.6   74    −16
  Sulfathiazole           5.2      8.0    83   −6        5.2   8.3   71    −15
  Cephapirin              6.9      7.8    75   1         12    12    94    −5
  Sulfapyridine           4.6      7.2    85   13        5.8   9.5   67    −13
  Tildipirosin            6.2      10     72   −8        6.0   20    87    5
  Cefquinome              6.1      7.2    97   −4        11    19    78    −16
  Sulfamerazine           3.8      5.9    89   11        6.7   8.7   70    −13
  Cefacetrile             12       13     80   **−26**   22    27    92    −5
  Cefalonium              6.7      7.3    78   3         8.7   8.7   93    −6
  Lincomycin              4.3      7.2    83   −12       2.3   4.4   92    **30**
  Epitetracycline         6.2      9.2    66   **22**    4.7   7.6   96    5
  Trimethoprim            3.4      7.8    90   −3        2.7   4.9   94    4
  Thiamphenicol           10       11     87   −13       13    13    92    −13
  Tulathromycin marker    5.6      8.6    81   −13       8.7   26    81    −18
  Marbofloxacin           6.1      7.0    87   **−27**   4.3   4.9   96    −11
  Sulfamethazine          4.1      7.2    85   −1        7.8   14    68    −13
  Epioxytetracycline      8.8      13     62   **40**    13    15    90    −3
  Norfloxacin             \-       \-     \-   \-        7.0   8.0   94    3
  Tetracycline            6.3      9.4    71   **27**    4.5   5.0   91    **40**
  Cefalexin               6.2      8.4    64   1         6.2   6.7   90    −7
  Oxytetracycline         6.7      8.1    63   10        4.4   5.2   90    1
  Ciprofloxacin           7.5      8.4    81   **−25**   6.1   7.5   95    −10
  Enrofloxacin            4.7      6.6    93   −16       4.1   5.9   99    −1
  Tulathromycin           8.3      16     69   10        7.5   13    94    5
  Danofloxacin            5.7      7.2    90   −17       4.2   5.0   97    3
  Cefazolin               8.4      9.0    83   −8        14    14    94    −11
  Sulfamethoxazole        7.7      9.7    88   −16       6.7   6.7   84    **−24**
  Difloxacin              5.0      7.4    93   −15       3.3   4.2   96    −13
  Ampicillin              6.6      8.0    68   −2        9.4   10    88    −10
  Sulfamonomethoxine      4.6      7.4    86   0         6.4   9.9   78    −19
  Florfenicol             9.8      16     90   −17       13    13    94    **−28**
  Cefoperazone            6.8      8.4    85   −13       16    18    103   **−25**
  Sarafloxacin            5.8      7.4    86   **−26**   4.8   6.6   99    **−22**
  Epichlorotetracycline   9.3      13     71   **65**    7.4   11    100   **22**
  Neospiramycin           7.8      16     67   12        7.3   12    86    13
  Chlortetracycline       5.8      7.7    69   **47**    5.7   7.2   92    **48**
  Spiramycin              8.4      17     74   20        4.5   7.6   91    **21**
  Sulfadimethoxine        4.5      8.1    88   −12       3.9   3.9   90    **−29**
  Sulfaquinoxaline        6.1      7.7    86   **−26**   4.6   4.8   91    **−38**
  Oxolinic Acid           4.9      6.7    97   4         2.6   6.6   96    −3
  Ceftiofur               7.5      9.7    72   **−21**   6.7   7.1   95    **−24**
  Gamithromycin           5.6      7.1    94   **55**    3.2   4.8   98    **26**
  Tilmicosin              6.9      10     88   **49**    3.2   4.4   95    **38**
  Doxycycline             7.0      9.5    69   1         6.6   7.4   95    10
  Nalidixic Acid          \-       \-     \-   \-        3.6   6.0   94    −3
  Penicillin G            7.9      9.0    85   **−21**   12    13    92    **37**
  Tiamulin                9.3      13     88   **−21**   2.5   4.1   98    −5
  Flumequine              4.3      7.3    95   −3        2.9   4.5   95    **52**
  Tylosin A               7.7      15     85   **29**    2.5   4.8   96    **54**
  Erythromycin A          4.9      8.6    89   **−27**   4.7   12    67    **−21**
  3-O-Acetyltylosin       9.3      16     88   **42**    3.7   5.0   95    **53**
  Oxacillin               6.0      11     83   **−29**   8.0   8.5   100   1
  Penicillin V            7.9      11     85   **−28**   7.5   7.7   99    6
  Cloxacillin             8.2      11     84   **−27**   9.8   12    110   **−25**
  Valnemulin              19       31     75   **−26**   2.7   5.4   108   **55**
  Dicloxacillin           6.7      10     81   **−25**   13    13    99    −10
  Nafcillin               5.0      8.2    84   **−7**    5.0   5.4   99    −19
  Tylvalosin              9.0      19     93   **50**    5.4   6.9   101   **90**
  Rifaximin               9.0      12     91   **33**    4.8   9.6   98    7

^a^ Nalidixic acid and norfloxacin were not included in muscle method since these antibiotics were introduced later; ^b^ For valnemulin (muscle), cefacetrile (milk) and cefquinome (milk) the method can be used only for screening purposes (inadequate accuracy); ^c^ Values of matrix effect (ME) in bold are considered significant (\>ǀ20ǀ%).
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###### 

Participation in Proficiency Test Schemes: comparison between methods.

  Method                      LC-Q-Orbitrap      LC-QqQ                                       
  --------------------------- ------------------ ----------------- ----- ----- -------------- ----------
  MI1432^-^A1/2014 ^a^        Milk               Sulfamethazine    144   96    103            57--150
  MI1432-A2/2014 ^a^          Milk               Amoxicillin       5     ND    Not assigned   \-
  M1435-A1/2014 ^a^           Pig muscle         Sulfamethazine    88    75    69             36--102
  Pig muscle                  Sulfadimethoxine   32                23    27    12--42         
  M1433-A2/2014 ^a^           Turkey muscle      Ciprofloxacin     5.5   5     5.6            3.2--8.1
  Turkey muscle               Enrofloxacin       173               152   160   92--227        
  MI1532-A1/2015 ^a^          Milk               Amoxicillin       16    ND    14             5.6--22
  MI1532-A2/2015 ^a^          Milk               Sulfamethazine    165   131   134            75--191
  MI1623-A1/2016 ^a^          Milk               Flumequine        91    111   88             47--129
  MI1623-A2/2016 ^a^          Milk               Oxytetracycline   93    55    91             49--132
  MI1715-A2/2017 ^a^          Milk               Danofloxacin      91    80    74             39--109
  484 (material C)/2018 ^b^   Bovine Muscle      Marbofloxacin     178   193   170            100--240
  484 (material C)/2018 ^b^   Bovine muscle      Oxytetracycline   89    79    106            59--152
  334/2019 ^b^                Bovine muscle      Ciprofloxacin     10    10    NA^c^          \-
  334/2019 ^b^                Bovine muscle      Enrofloxacin      82    84    NA^c^          \-
  544/2019 ^b^                Bovine muscle      Tylosin A         54    87    NA^c^          \-

^a^ Test Veritas, Padova, Italy; ^b^ RIKILT, Wageningen, Netherlands; ^c^ The final Report is not yet available.
